According to a filing submitted to the U.S. Securities and Exchange Commission (SEC), GlaxoSmithKline has decided to terminate its collaboration and licensing agreement with Alector Inc., with the termination to take effect on January 2, 2027.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This move marks the imminent end of the collaboration between the two companies on specific research and development projects.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Bio-Techne shareholders vote to adopt Merck KGaA acquisition agreement at special meeting
Bitget•2026/09/23 13:20
Euro: Downside bias toward 1.1400 against US Dollar – UOB
FXStreet•2026/09/23 13:19
Sector Update: Healthcare Stocks Mixed Premarket Wednesday
MT newswire•2026/09/23 13:19
Crypto prices
More
Bitcoin
BTC
$85,440.94
-0.57%
Ethereum
ETH
$2,712.1
-1.32%
Tether USDt
USDT
$0.9997
-0.02%
BNB
BNB
$777.46
-1.65%
XRP
XRP
$1.57
+1.10%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$116.52
-0.75%
TRON
TRX
$0.3416
-0.94%
Zcash
ZEC
$1,630.63
+7.44%
Hyperliquid
HYPE
$94.81
-0.53%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now